Last updated 2026-06-18
- Raised $3M funding round, Oct 2018
Total raised
$3.0M
Last: 2018-10
Stage
Seed
Founded
2018
Headcount
3
HQ
, Israel
Sector
Health Tech & Life Sciences
About
Pink Biopharma is a drug-discovery company that is developing a therapeutic monoclonal antibody as a natural-killer immune checkpoint inhibitor for a variety of cancers, specifically acute myeloid leukemia. The company is a portfolio company of the FutuRx biotech incubator.
Funding history · 1 round · $3.0M total
2018-10
$3.0M
Q&A
- What is Pink Biopharma's primary focus?
- Pink Biopharma is a drug-discovery company developing a therapeutic monoclonal antibody as a natural-killer immune checkpoint inhibitor for various cancers, specifically acute myeloid leukemia.
- When was Pink Biopharma founded?
- Pink Biopharma was founded in May 2018.
- What is the current status of Pink Biopharma?
- Pink Biopharma is currently inactive, having ceased operations in July 2021.
- How much funding has Pink Biopharma raised in total?
- Pink Biopharma has raised a total of $3,000,000.
- Which investor participated in Pink Biopharma's funding round?
- FutuRx participated in Pink Biopharma's funding round in October 2018.
- What is Pink Biopharma's employee count?
- Pink Biopharma has 1-10 employees.
- Where is Pink Biopharma's headquarters located?
- Pink Biopharma's headquarters is located at Ilan Ramon 2, Ness Ziona, Israel.
Team · 3
Founder · Co-founder & CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
cellsdrug-discoveryantibodiespharmaceuticalsoncologycancerimmunotherapyimmunologybiotechnologyhospitals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2018-5 |
|---|---|
| Employees (exact) | 3 |
| Status reason | Non Active, Jul 2021 ceased to operate |